Spinal fusion stimulator earns US patent

Theragen’s ActaStim-S spine fusion bone growth stimulator system received a U.S. patent.

Advertisement

ActaStim-S promotes healing and uses a mobile app to allow patients to track their progress, according to an Aug. 18 news release from the devicemaker. The patent focuses on ensuring connectivity does not interfere with the device’s ease of use.

“Spinal fusion is a healing process, often characterized as a race to achieve solid fusion before failure of the implanted hardware,” Theragen CEO Chris McAuliffe said in the release. “That’s why we’ve taken a user-centric approach, designing a more wearable device that also offers a digital health component that gives patients the unique opportunity to engage in, follow and truly impact their own recovery.”

Advertisement

Next Up in Spinal Tech

  • The highest-paid CEOs at spine and orthopedic medtech companies saw total compensation of more than $20 million. Here is how…

  • Elon Musk’s brain-implant company, Neuralink, may soon have a new competitor in the market.  Neurotechnology startup Precision Neuroscience has earned…

  • Alphatec CEO Patrick Miles earned about $6.2 million in total compensation, according to the company’s April 11 Securities and Exchange…

Advertisement

Comments are closed.